Terms: = Lung cancer AND MTOR, FRAP2, FRAP1, 2475, ENSG00000198793, P42345, RAPT1, RAFT1, FRAP, FLJ44809 AND Diagnosis
90 results:
1. Lymphangioleiomyomatosis in patients with tuberous sclerosis: a national centre audit.
Johnson J; Somerfield W; Johnson SR
Orphanet J Rare Dis; 2024 Mar; 19(1):137. PubMed ID: 38532450
[TBL] [Abstract] [Full Text] [Related]
2. Unveiling the potential effects of resveratrol in lung cancer treatment: Mechanisms and nanoparticle-based drug delivery strategies.
Najafiyan B; Bokaii Hosseini Z; Esmaelian S; Firuzpour F; Rahimipour Anaraki S; Kalantari L; Hheidari A; Mesgari H; Nabi-Afjadi M
Biomed Pharmacother; 2024 Mar; 172():116207. PubMed ID: 38295754
[TBL] [Abstract] [Full Text] [Related]
3. [Study on the Role and Mechanism of METTL3 Mediating the Up-regulation of
m6A Modified Long Non-coding RNA THAP7-AS1 in Promoting the Occurrence of
lung cancer].
Zhang Y; Wang Y; Liu M
Zhongguo Fei Ai Za Zhi; 2024 Jan; 26(12):919-933. PubMed ID: 38163978
[TBL] [Abstract] [Full Text] [Related]
4. [Genetic diffuse cystic lung disease in adults].
Diesler R; Ahmad K; Chalabreysse L; Glérant JC; Harzallah I; Touraine R; Si-Mohamed S; Cottin V
Rev Mal Respir; 2024 Jan; 41(1):69-88. PubMed ID: 37951745
[TBL] [Abstract] [Full Text] [Related]
5. CCL2 promotes metastasis and epithelial-mesenchymal transition of non-small cell lung cancer via PI3K/Akt/mtor and autophagy pathways.
Xu H; Wang J; Al-Nusaif M; Ma H; Le W
Cell Prolif; 2024 Mar; 57(3):e13560. PubMed ID: 37850256
[TBL] [Abstract] [Full Text] [Related]
6. METTL3 exerts synergistic effects on m6A methylation and histone modification to regulate the function of VGF in lung adenocarcinoma.
Shi K; Sa R; Dou L; Wu Y; Dong Z; Fu X; Yu H
Clin Epigenetics; 2023 Sep; 15(1):153. PubMed ID: 37742030
[TBL] [Abstract] [Full Text] [Related]
7. High expression of ENPP2 is an independent predictor of poor prognosis in liver cancer.
Meng J; Ruan X; Wei F; Xue Q
Medicine (Baltimore); 2023 Aug; 102(31):e34480. PubMed ID: 37543832
[TBL] [Abstract] [Full Text] [Related]
8. Spontaneous pneumothoraces during pregnancy in patients with lymphangioleiomyomatosis.
Munshi A; Hyslop AD; Kopras EJ; Gupta N
Respir Investig; 2023 Sep; 61(5):632-635. PubMed ID: 37451227
[TBL] [Abstract] [Full Text] [Related]
9. Clinicogenomic factors and treatment patterns among patients with advanced non-small cell lung cancer with or without brain metastases in the United States.
Smyth EN; John J; Tiu RV; Willard MD; Beyrer JK; Bowman L; Sheffield KM; Han Y; Brastianos PK
Oncologist; 2023 Nov; 28(11):e1075-e1091. PubMed ID: 37358877
[TBL] [Abstract] [Full Text] [Related]
10. Macrophage-derived exosomal miR-342-3p promotes the progression of renal cell carcinoma through the NEDD4L/CEP55 axis.
Feng J; Xu B; Dai C; Wang Y; Xie G; Yang W; Zhang B; Li X; Wang J
Oncol Res; 2021; 29(5):331-349. PubMed ID: 37305161
[TBL] [Abstract] [Full Text] [Related]
11. Liquid Biopsy Snapshots of Key Phosphoproteomic Pathways in lung cancer Patients for diagnosis and Therapy Monitoring.
Ahmed M; Wuethrich A; Constantin N; Shanmugasundaram KB; Mainwaring P; Kulasinghe A; O'Leary C; O'Byrne K; Sina AA; Carrascosa LG; Trau M
Anal Chem; 2023 Jun; 95(22):8522-8532. PubMed ID: 37224231
[TBL] [Abstract] [Full Text] [Related]
12. Pulmonary benign metastasizing leiomyoma in patients aged 45 years and younger: clinical features and novelty in treatment.
Su H; Fan R; Yang H; You Y; Zhu L; Feng F
BMC Pulm Med; 2023 May; 23(1):168. PubMed ID: 37189093
[TBL] [Abstract] [Full Text] [Related]
13. Junctional adhesion molecule-like protein as a novel target for kaempferol to ameliorate lung adenocarcinoma.
Wu Q; Wang YB; Che XW; Wang H; Wang W
J Integr Med; 2023 May; 21(3):268-276. PubMed ID: 37069006
[TBL] [Abstract] [Full Text] [Related]
14. The roles and mechanisms of circular RNAs related to mtor in cancers.
Cao C; Wang Y; Wu X; Li Z; Guo J; Sun W
J Clin Lab Anal; 2022 Dec; 36(12):e24783. PubMed ID: 36426933
[TBL] [Abstract] [Full Text] [Related]
15. Clinical phenotypes and long-term outcome of kidney involvement in Erdheim-Chester histiocytosis.
Chazal T; Pegoraro F; Manari G; Bettiol A; Maniscalco V; Gelain E; Charlotte F; Mazor RD; Renard-Penna R; Amoura Z; Cohen-Aubart F; Haroche J; Izzedine H; Vaglio A
Kidney Int; 2023 Jan; 103(1):177-186. PubMed ID: 36374823
[TBL] [Abstract] [Full Text] [Related]
16. Uterine Leiomyosarcoma Masquerading as a Malignant Perivascular Epithelioid Cell Tumor: A Diagnostic Challenge.
Natsume T; Yoshida H; Nishikawa T; Kikkawa N; Naka T; Kobayashi-Kato M; Tanase Y; Uno M; Ishikawa M; Kato T
Int J Surg Pathol; 2023 Aug; 31(5):778-784. PubMed ID: 36310451
[TBL] [Abstract] [Full Text] [Related]
17. Relationship between the microRNAs and PI3K/AKT/mtor axis: Focus on non-small cell lung cancer.
Lin Y; Zhang L; Ding X; Chen C; Meng M; Ke Y; Wang W
Pathol Res Pract; 2022 Nov; 239():154093. PubMed ID: 36183437
[TBL] [Abstract] [Full Text] [Related]
18. Pulmonary toxicity of mtor inhibitors. Comparisons of two populations: Solid organ recipients and cancer patients.
Gendarme S; Pastré J; Billaud EM; Gibault L; Guillemain R; Oudard S; Medioni J; Lillo-Lelouet A; Israël-Biet D
Therapie; 2023; 78(3):267-278. PubMed ID: 35729008
[TBL] [Abstract] [Full Text] [Related]
19. Combining plasma extracellular vesicle Let-7b-5p, miR-184 and circulating miR-22-3p levels for NSCLC diagnosis and drug resistance prediction.
Vadla GP; Daghat B; Patterson N; Ahmad V; Perez G; Garcia A; Manjunath Y; Kaifi JT; Li G; Chabu CY
Sci Rep; 2022 Apr; 12(1):6693. PubMed ID: 35461372
[TBL] [Abstract] [Full Text] [Related]
20. Dysregulated
Sui J; Zhao Q; Zhang Y; Liang G
DNA Cell Biol; 2022 Mar; 41(3):319-329. PubMed ID: 35244469
[TBL] [Abstract] [Full Text] [Related]
[Next]
